https://www.taxtmi.com/news?id=53402 A Joint Venture will be formed with Akums holding 51% and the nominated state instrumentality holding 49%, governed by a Board representing both partners. Both parties will contribute to establishment and operations in proportion to shareholding. Commercial supplies are contingent on timely establishment and regulatory approvals. The facility will manufacture multiple dosage forms including tablets, capsules, liquids, injectables and beta-lactam products to serve domestic needs and enable future exports. The Government has committed to procure essential medicines from Akums' facilities to support national healthcare demand. en-us Sat, 23 Aug 2025 17:46:03 +0530 Sat, 23 Aug 2025 17:46:03 +0530 TaxTMI RSS Generator https://www.taxtmi.com/news?id=53402 A Joint Venture will be formed with Akums holding 51% and the nominated state instrumentality holding 49%, governed by a Board representing both partners. Both parties will contribute to establishment and operations in proportion to shareholding. Commercial supplies are contingent on timely establishment and regulatory approvals. The facility will manufacture multiple dosage forms including tablets, capsules, liquids, injectables and beta-lactam products to serve domestic needs and enable future exports. The Government has committed to procure essential medicines from Akums' facilities to support national healthcare demand. News - Sat, 23 Aug 2025 17:46:03 +0530 https://www.taxtmi.com/news?id=53402